Forbes January 24, 2025
William A. Haseltine

Gene editing is now reaching the mainstream, ushering in a new era of genetic manipulation. Traditionally, inserting or deleting entire genes, regulating their expression, and altering specific sequences of significant genes have been performed as separate processes. However, a new development has emerged that allows these three critical changes to be made simultaneously, significantly enhancing the capabilities of gene therapies.

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, activation, and repression into a single, compact system. Much like a Swiss Army knife, mvGPT is a marvel of compact engineering—a genetic powerhouse of versatility and precision. As highlighted in a study by Rice University, the potential of mvGPT, especially when used alongside...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
People on Ozempic may have fewer heart attacks, strokes, addictions—but more nausea, vomiting, stomach pain
Exploring the Future of Genomics and Life Sciences
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Novo Nordisk Obesity Drug Shows 22% Weight Loss, But Lack of Safety Detail Is a Sticking Point
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks

Share This Article